McKesson (MCK) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

McKesson Revenue Highlights

Latest Revenue (Y)

$403.43B

Latest Revenue (Q)

$106.16B

Main Segment (Y)

North American Pharmaceutical Segment

Main Geography (Y)

International Segment

McKesson Revenue by Period

McKesson Revenue by Year

Date	Revenue	Change
2026-03-31	$403.43B	12.36%
2025-03-31	$359.05B	16.22%
2024-03-31	$308.95B	11.65%
2023-03-31	$276.71B	4.83%
2022-03-31	$263.97B	10.80%
2021-03-31	$238.23B	3.11%
2020-03-31	$231.05B	7.81%
2019-03-31	$214.32B	2.86%
2018-03-31	$208.36B	4.95%
2017-03-31	$198.53B	4.01%
2016-03-31	$190.88B	6.61%
2015-03-31	$179.04B	30.11%
2014-03-31	$137.61B	12.38%
2013-03-31	$122.45B	-0.23%
2012-03-31	$122.73B	9.50%
2011-03-31	$112.08B	3.11%
2010-03-31	$108.70B	1.94%
2009-03-31	$106.63B	4.85%
2008-03-31	$101.70B	9.39%
2007-03-31	$92.98B	5.60%
2006-03-31	$88.05B	9.36%
2005-03-31	$80.51B	15.84%
2004-03-31	$69.51B	21.68%
2003-03-31	$57.12B	14.23%
2002-03-31	$50.01B	19.03%
2001-03-31	$42.01B	14.36%
2000-03-31	$36.73B	20.91%
1999-03-31	$30.38B	45.67%
1998-03-31	$20.86B	61.85%
1997-03-31	$12.89B	-6.05%
1996-03-31	$13.72B	4.00%
1995-03-31	$13.19B	-

McKesson generated $403.43B in revenue during NA 2026, up 12.36% compared to the previous quarter, and up 169.35% compared to the same period a year ago.

McKesson Revenue by Quarter

Date	Revenue	Change
2025-12-31	$106.16B	2.92%
2025-09-30	$103.15B	5.44%
2025-06-30	$97.83B	7.71%
2025-03-31	$90.82B	-4.69%
2024-12-31	$95.29B	1.75%
2024-09-30	$93.65B	18.12%
2024-06-30	$79.28B	3.83%
2024-03-31	$76.36B	-5.62%
2023-12-31	$80.90B	4.77%
2023-09-30	$77.22B	3.67%
2023-06-30	$74.48B	8.09%
2023-03-31	$68.91B	-2.24%
2022-12-31	$70.49B	0.47%
2022-09-30	$70.16B	4.47%
2022-06-30	$67.15B	1.59%
2022-03-31	$66.10B	-3.66%
2021-12-31	$68.61B	3.06%
2021-09-30	$66.58B	6.23%
2021-06-30	$62.67B	5.97%
2021-03-31	$59.14B	-5.52%
2020-12-31	$62.60B	2.95%
2020-09-30	$60.81B	9.21%
2020-06-30	$55.68B	-4.88%
2020-03-31	$58.53B	-1.08%
2019-12-31	$59.17B	2.70%
2019-09-30	$57.62B	3.39%
2019-06-30	$55.73B	6.29%
2019-03-31	$52.43B	-6.72%
2018-12-31	$56.21B	5.90%
2018-09-30	$53.08B	0.89%
2018-06-30	$52.61B	1.90%
2018-03-31	$51.63B	-3.71%
2017-12-31	$53.62B	2.99%
2017-09-30	$52.06B	1.98%
2017-06-30	$51.05B	4.80%
2017-03-31	$48.71B	-2.83%
2016-12-31	$50.13B	0.35%
2016-09-30	$49.96B	0.45%
2016-06-30	$49.73B	6.54%
2016-03-31	$46.68B	-2.55%
2015-12-31	$47.90B	-1.77%
2015-09-30	$48.76B	2.56%
2015-06-30	$47.55B	10.00%
2015-03-31	$43.22B	-8.04%
2014-12-31	$47.01B	5.02%
2014-09-30	$44.76B	1.59%
2014-06-30	$44.06B	15.51%
2014-03-31	$38.14B	11.18%
2013-12-31	$34.31B	4.10%
2013-09-30	$32.95B	2.32%
2013-06-30	$32.21B	5.19%
2013-03-31	$30.62B	-1.82%
2012-12-31	$31.19B	4.48%
2012-09-30	$29.85B	-3.08%
2012-06-30	$30.80B	-2.84%
2012-03-31	$31.70B	2.79%
2011-12-31	$30.84B	2.06%
2011-09-30	$30.22B	0.79%
2011-06-30	$29.98B	3.91%
2011-03-31	$28.85B	2.15%
2010-12-31	$28.25B	2.59%
2010-09-30	$27.53B	0.31%
2010-06-30	$27.45B	3.03%
2010-03-31	$26.64B	-5.76%
2009-12-31	$28.27B	4.21%
2009-09-30	$27.13B	1.77%
2009-06-30	$26.66B	1.65%
2009-03-31	$26.22B	-3.34%
2008-12-31	$27.13B	2.09%
2008-09-30	$26.57B	-0.49%
2008-06-30	$26.70B	1.80%
2008-03-31	$26.23B	-

McKesson generated $106.16B in revenue during Q3 2026, up 2.92% compared to the previous quarter, and up 113.35% compared to the same period a year ago.

McKesson Revenue Breakdown

McKesson Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Prescription Technology Solutions Segment	$5.80B	$4.39B	$3.86B	-	-
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment	$1.04B	-	-	-	-
Oncology And Multispecialty Segment	$48.42B	-	-	-	-
North American Pharmaceutical Segment	$336.65B	-	-	-	-
Medical-Surgical Solutions Segment	$11.51B	$11.39B	$11.31B	$11.11B	$11.61B
U.S. Pharmaceutical Segment	-	$327.72B	$278.74B	$240.62B	$212.15B
Prescription Technology Solutions	-	$5.22B	$4.77B	$4.39B	-
International Segment	-	$14.72B	$14.13B	$20.60B	-

McKesson's latest annual revenue breakdown by segment (product or service), as of Mar 26: North American Pharmaceutical Segment (83.45%), Oncology And Multispecialty Segment (12.00%), Medical-Surgical Solutions Segment (2.85%), Prescription Technology Solutions Segment (1.44%), and Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment (0.26%).

Quarterly Revenue by Product

Product/Service	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Oncology And Multispecialty Segment	$23.37B	$13.01B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
North American Pharmaceutical Segment	$161.85B	$88.32B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Medical-Surgical Solutions Segment	$2.87B	$2.99B	$2.95B	$2.70B	$2.85B	$2.95B	$2.95B	$2.84B	$3.03B	$2.83B	$2.61B	$2.69B	$2.99B	$2.84B	$2.59B	$2.87B	$3.08B	$3.12B	$2.53B	$2.71B
Prescription Technology Solutions Segment	$2.93B	$1.50B	$1.21B	$789.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment	$406.00M	$335.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prescription Technology Solutions	-	$1.50B	$1.38B	$1.43B	$1.34B	$1.37B	$1.26B	$1.18B	$1.21B	$1.14B	$1.24B	$1.12B	$1.02B	$1.07B	$1.03B	$932.00M	$881.00M	-	-	-
U.S. Pharmaceutical Segment	-	-	-	$89.95B	$83.17B	$87.11B	$85.73B	$68.79B	$73.02B	$69.77B	$67.16B	$61.68B	$61.93B	$60.06B	$56.95B	$53.68B	$55.04B	$53.41B	$50.02B	$47.04B
International Segment	-	-	-	$3.74B	$3.46B	$3.86B	$3.71B	$3.55B	$3.64B	$3.48B	$3.47B	$3.36B	$4.45B	$6.24B	$6.55B	$8.53B	$9.46B	$9.11B	$9.25B	$8.60B

McKesson's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: North American Pharmaceutical Segment (84.55%), Oncology And Multispecialty Segment (12.21%), Prescription Technology Solutions Segment (1.53%), Medical-Surgical Solutions Segment (1.50%), and Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment (0.21%).

McKesson Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 25	Mar 24	Mar 23	Mar 20	Mar 19
International Segment	$14.72B	$14.13B	$20.60B	$38.34B	-
Non-US	-	-	-	$38.34B	$38.02B
UNITED STATES	-	-	-	$192.71B	$176.30B

McKesson's latest annual revenue breakdown by geography, as of Mar 25: International Segment (100.00%).

Quarterly Revenue by Country

Country	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18
International Segment	$3.74B	$3.46B	$3.86B	$3.71B	$3.55B	$3.64B	$8.55B	-	-	-	-	-	-	-	-
Non-US	-	-	-	-	-	-	$8.55B	$9.75B	$9.86B	$9.32B	$9.41B	$9.32B	$9.69B	$9.30B	$9.72B
UNITED STATES	-	-	-	-	-	-	$47.13B	$48.78B	$49.31B	$48.29B	$46.32B	$43.11B	$46.52B	$43.77B	$42.89B

McKesson's latest quarterly revenue breakdown by geography, as of Jun 25: International Segment (100.00%).

McKesson Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
MCK	McKesson	$403.43B	$106.16B
CVS	CVS Health	$402.07B	$102.87B
COR	Cencora	$321.33B	$85.93B
CAH	Cardinal Health	$222.58B	$60.94B
HCA	HCA Healthcare	$75.60B	$19.11B
BMY	Bristol-Myers Squibb	$48.19B	$11.49B
SNY	Sanofi	$43.07B	$11.12B
MDT	Medtronic	$33.54B	$9.02B
GSK	GSK	$30.33B	$7.36B
SYK	Stryker	$25.12B	$6.02B
VRTX	Vertex Pharmaceuticals	$12.00B	$2.99B

MCK Revenue FAQ

What is McKesson’s yearly revenue?

McKesson's yearly revenue for 2026 was $403.43B, representing an increase of 12.36% compared to 2025. The company's yearly revenue for 2025 was $359.05B, representing an increase of 16.22% compared to 2024. MCK's yearly revenue for 2024 was $308.95B, representing an increase of 11.65% compared to 2023.

What is McKesson’s quarterly revenue?

McKesson's quarterly revenue for Q3 2026 was $106.16B, a 2.92% increase from the previous quarter (Q2 2026), and a 11.40% increase year-over-year (Q3 2025). The company's quarterly revenue for Q2 2026 was $103.15B, a 5.44% increase from the previous quarter (Q1 2026), and a 10.14% increase year-over-year (Q2 2025). MCK's quarterly revenue for Q1 2026 was $97.83B, a 7.71% increase from the previous quarter (Q4 2025), and a 23.39% increase year-over-year (Q1 2025).

What is McKesson’s revenue growth rate?

McKesson's revenue growth rate for the last 3 years (2024-2026) was 30.58%, and for the last 5 years (2022-2026) was 52.83%.

What are McKesson’s revenue streams?

McKesson's revenue streams in r 26 are Prescription Technology Solutions Segment, Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment, Oncology And Multispecialty Segment, North American Pharmaceutical Segment, and Medical-Surgical Solutions Segment. Prescription Technology Solutions Segment generated $5.8B in revenue, accounting 1.44% of the company's total revenue, up 32.32% year-over-year. Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment generated $1.04B in revenue, accounting 0.26% of the company's total revenue Oncology And Multispecialty Segment generated $48.42B in revenue, accounting 12.00% of the company's total revenue North American Pharmaceutical Segment generated $336.65B in revenue, accounting 83.45% of the company's total revenue Medical-Surgical Solutions Segment generated $11.51B in revenue, accounting 2.85% of the company's total revenue, up 1.06% year-over-year.

What is McKesson’s main source of revenue?

For the fiscal year ending Mar 26, the largest source of revenue of McKesson was North American Pharmaceutical Segment. This segment made a revenue of $336.65B, representing 83.45% of the company's total revenue.